• Title/Summary/Keyword: Antineoplastic Agents

Search Result 51, Processing Time 0.03 seconds

Biological Monitoring on the Absorption of Antineoplastic Drugs in Nursing Personnel (항암제 취급간호사의 항암제 체내흡수에 관한 조사)

  • 김봉임
    • Journal of Korean Academy of Nursing
    • /
    • v.27 no.3
    • /
    • pp.520-530
    • /
    • 1997
  • Antineoplastic agents may exhibit effects not only in patients therapeutically exposed, but also in health workers who prepare and administer these drugs. This study was done to clarify whether nurses who handle anticancer drugs show signs of drug absorption. The experimental group was 14 nurses handling anticancer drugs at three medical wards of a hospital in J city ; the control group was 12 psychiatric nurses at the same hospital. The test materials were the nurses' 24hr urine specimens, which were concentrated by XAD-2 column chromatograpy. Tester strains were TA98(±S9mix), TA100(±S9 mix), TA1535(±S9 mix) and TA1537(±S9 mix) : the salmonella mammalian microsomal test (Ames test) was used for the urinary mutagenicity assay. The results are summarized as follow : 1. In qualitative analysis of the results, both experimental group and control group showed 15.4% urine toxicity. 2. The experimental group revealed significantly higher urinary mutagenicity both in the activation method test and non-activation method test of the tester strains TA98, TA100 and TA1535. In the case of TA1537, the two groups showed no difference in the non-activation method test, but the activation method revealed a difference. 3. In urinary mutagenicity of the experimental group by ward career, there was a significant difference between the group with more than 20 months experience and the group with less than 20 months on the tester strains TA98, TA100, and TA1537. No Significant difference was found between two groups by the tester strain TA1535.

  • PDF

Synthesis and Antitumor Activity of Antineoplaston A10 Analogs as Potential Antineoplastic Agents (항암제 안티네오플라스톤 A10의 동족체합성 및 항암 활성)

  • Choi, Bo-Gil;Seo, Hee-Kyoung;Kim, Ok-Young;Chung, Bung-Ho;Oh, In-Jun;Cho, Won-Jea;Cheon, Seung-Hoon;Park, Min-Soo;Choi, Sang-Un;Lee, Chong-Ock
    • YAKHAK HOEJI
    • /
    • v.41 no.3
    • /
    • pp.283-293
    • /
    • 1997
  • Some analogs and their Mannich bases of Antineoplaston A10 (A10) were synthesized. Chemical yield for the 2-(or 3-)thienyl, benzol, and phenylpropionyl analogs were high but 1-naphthyl analog was synthesized in low yield. The Mannich bases formation of these analogs with morpholine went verywell compared to other bases. 1-Naphthyl, 4-nitrobenzoyl, and phenylpropionyl analogs of A10 showed weak in vitro activity but the other A10 analogs showed weaker or no activity at 10-1000mcg/ml. But their Mannich bases containing A10analogs showed good in vitro activity compared to simple A10 analogs.

  • PDF

STDIES ON ANTITUMOR AGENTS FROM HIGHER PLANTS (制癌作用)

  • Itokawa, Hideji
    • Korean Journal of Plant Resources
    • /
    • v.6 no.1
    • /
    • pp.13-23
    • /
    • 1993
  • To data, many types of compounds having antineoplastic activity have been isolated from higher plants, that is, alkalodids, terpenes, lignans, steroids and so on. Some of ther were isolated from Indonesian plants, Curcuma xanthorrhiza and Eurycoma longifolia. Bisaborane type compounds were compounds were isolated as antimeoplastic compounds againest Sarcoma 180A from C. xanthorrhiza, and quassinoids and euryrene type triterpenes from triterpenes from El longifolia. Casearines, a kind of diterpene, had been isolated as cytotxic components from Casearia sylvestris distributed in South America. RA series Cyclic hexapeptides isolated from Rubia akane and R. cordifolia also have strong antineoplastic activity against various types of tumors. Till now, 16 kinds of RA series compounds were isolated and named as RA-I~XVI. Moreover, monoglucoside of RA-V newly isolated from same plant. Many kinds of derivatives including natural RA compounds were tested for QSAR, and one of them, RA-VII was screened up as a most suitable substance as an antitumor agent. RA-VII(=RA 700) has strong cytotoxic activity against KB cells, P388 lymphocytic leukemia and MM2 mammary carcinoma cells. In some solution, three conformers of RA-VII were observed by NMR. It was discussed the relationship between conformation and activity. Total synthesis was already completed, but there is left room for improvement. Phase I clinical trials for RA-VII has been finished, then Phase II trials will be started before long.

  • PDF

Analysis of Research Subject Network in the Field of Oncogene (암유전자 연구주제 네트워크 분석)

  • Jang, Hae-Lan;Kang, Gil-Won;Lee, Eun-Jung;Kim, Seung-Ryul;Lee, Young-Sung
    • Journal of Korea Technology Innovation Society
    • /
    • v.15 no.2
    • /
    • pp.369-399
    • /
    • 2012
  • Purpose: Health technology research & development is an important area to leading future. This study examined the current trends for 'oncogene' based on the research subject network to deduce a research front. Method: Papers were extracted from PubMed database using MeSH term for studies on 'oncogenes' and further categorized as papers published by Korean. Keywords were collected from all of articles. Research subject network was generated by keywords. Research subject network was analyzed by weighted degree centrality based social network analysis and transition of research subjects was analyzed by the time series. Results: On 'oncogenes', 'Genes, ras', 'Apoptosis', 'Signal Transduction' had a high degree centrality and currently 'Antineoplastic Agents', 'Prognosis', and 'Tumor Markers, Biological' were widely conducted. Conclusion: Consistency of research trend pattern was found by analyzing oncogene network with compromised to international vs. domestic trends. Analyzing keyword networks in various subject area, those will allow us to predict the research progress and propose evidence of research & developmental strategy.

  • PDF

Studies on the Synthesis and Antitumor Actiities of Potential Antineoplastic Agents. IV. Synthesis and Antitumor Activities of N-Substituted-p-Arsanilic Acid (제암성물질의 합성및 항종양시험에 관한 연구 IV N-치환, p-Arsanilic Acid 유도체의 합성 및 항종양시험)

  • 정원근;천문우;김중협;이남복
    • YAKHAK HOEJI
    • /
    • v.15 no.1
    • /
    • pp.16-23
    • /
    • 1971
  • Seven organic arsine compounds are synthesized as potential anti-tumor agents are subjected to the screening test of activity against SN-36 Leukemia, Sarcoma 180 and Ehrlich ascites carcinoma. Three compounds, namely N-(5-Nitrofroyl)-p-arsanilic acid, N-(2, 4-Dihydroxybenzoethyl)-p-arsanilic acid and N-$\alpha$(p-arsanilido) acetyl thiourea of the all synthesized compounds showed comparatively potential activities against experimental ascitic tumors both through cytological findings and survival duration.

  • PDF

Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance

  • Baek, Dong Won;Park, Ji-Young;Lee, Soo Jung;Chae, Yee Soo
    • Journal of Yeungnam Medical Science
    • /
    • v.37 no.3
    • /
    • pp.230-235
    • /
    • 2020
  • Systemic therapy for metastatic triple-negative breast cancer (TNBC) still remains challenging because there are no targeted agents or endocrine therapies currently available. The present case report documents the successful use of cisplatin monotherapy to manage a heavily pretreated TNBC patient showing poor response to therapy. The patient was a 51-year-old woman who had already undergone several lines of systemic chemotherapy for widespread TNBC. Although the mutation analysis performed on DNA isolated from blood cells and progressed lesion samples confirmed the tumor to be germline BRCA wild-type, cisplatin monotherapy was administered based on the increasing evidence of safety and efficacy of platinum for breast cancer. After three cycles of cisplatin treatment, the patient's metastatic lesions dramatically improved without any major toxicity, and she completed 17 cycles with good response. This case study indicates that patients with heavily pretreated TNBC can potentially achieve a good response to cisplatin monotherapy.

DNA-Damage Inducible 1 is a Property of Human Non-Small Cell Lung Cancer

  • Lee, Ji-Yeon;Kang, Eun-Sil;Lim, Beom-Jin;Chang, Yoon-Soo;Kim, Se-Kyu
    • Tuberculosis and Respiratory Diseases
    • /
    • v.72 no.2
    • /
    • pp.124-131
    • /
    • 2012
  • Background: DNA damage-inducible 1 (Ddi1), one of the ubiquitin-like and ubiquitin-associated family of proteins, may function in the regulation of the ubiquitin-proteasome pathway, which has been validated as a target for antineoplastic therapy. We investigated Ddi1 expression in human lung cancer tissues and evaluated the relationship of this expression pattern with clinicopathological factors in patients with non-small-cell lung cancer (NSCLC). Methods: Ddi1 expression was examined by immunohistochemistry in tumor tissues from 97 patients with stage I NSCLC, who had undergone curative surgical resection at two tertiary referral hospitals from 1993~2004. None of the patients received preoperative chemotherapy and/or radiation therapy. Results: Thirty-nine (40.2%) of the 97 cases were positive for Ddi1. Ddi1 expression was dominantly seen in cytoplasm rather than in the nuclei of cancer cells in all histological types, whereas adjacent nontumoral lung tissue showed negative Ddi1 staining in most cases. Ddi1 expression tended to increase in well-differentiated tumors but without statistical significance. Positive Ddi1 expression was associated with a tendency for better disease-free survival and disease-specific survival, although the difference was not significant. Conclusion: Ddi1 expression is a property of NSCLC. Because Ddi1 could be a potential target for cancer therapy, more research is needed to evaluate its role in NSCLC.

The Longitudinal Study on the Calorie and Protein Intakes and Food Choices in Gastrectomy Patients who Receiving Adjuvant Chemotherapy (수술 후 Cisplatin을 투여받는 위암 환자의 구강영양섭취 실태 분석)

  • 전명희;왕수경
    • Journal of Korean Academy of Nursing
    • /
    • v.32 no.2
    • /
    • pp.206-219
    • /
    • 2002
  • This study was conducted to investigate nutrient and food choices in gastric cancer patients receiving Cisplatin after surgery. Ten patients were followed from the fist day of the first cycle to the last date of the 6th the cycle of the chemotherapy. The subjects kept daily self record of dietary intake and the period of nausea/vomiting during 6 cycles. Using Computer Aided Nutritional Analysis Program, the degree of Calorie, carbohydrate, protein, fat and fluid intakes according the chemotherapy period. The reseacher developed food intake rating scale, and then three dietitians analysed the oral intakes according to the type of foods. As the results of this study, during the chemotherapy cancer patients are intakes much fewer calorie, protein and fluids than recommended dietary allowance. Oral intake was worsen as treatment proceed. During the chemotherapy periods most of the patients choose fruits, vegitables, steam rice, porridge, yogurt and the beam soup to overcome nausea and vomiting. In order to promote oral intake for chemotherapy patients, the researcher strongly suggest that indiviual food preform should be considered.

Studies on the Synthesis and Antineoplastic Activities of Potential Antitumor Agents. III. Screening Test of Antitumor Activities of a few plant Extracts against Experimental Tu mors (제암성성질의 합성및 항종양시험에 관한 연구 III 수종한국산식물의 Ethanol Extract의 항종양시험)

  • 정보섭;정원근;김중협;천문우
    • YAKHAK HOEJI
    • /
    • v.14 no.3_4
    • /
    • pp.51-53
    • /
    • 1970
  • Alcohol extracts of six plant namely Coix agrestis L$_{OUREIRO}$, Chloranthus Japonicus (Siebi) N$_{AKAI}$, Ajuga Spectabilis N$_{AKAI}$, Juglans mandsuria Max., Cirsium Macki var Ussuriense $K_{ITA}$ and Sasamorpha Purpurascense (Hack) N$_{AKAI}$ were subjected to the screening tests for anti-tumor activities against SN-36 Leukemia, Sarcoma 180 and Ehrlich ascites carcinoma. Of the six extracts, Ajuga Spectabilis N$_{AKAI}$ and Coix agrestis L$_{OUREIRO}$ were found to be potential in survival effect of tumor transplanted mice.

  • PDF

A Case of Capecitabine-Induced Sarcoidosis

  • Kang, Shin-Myung;Baek, Ji-Yeon;HwangBo, Bin;Kim, Hyae-Young;Lee, Geon-Kook;Lee, Hee-Seok
    • Tuberculosis and Respiratory Diseases
    • /
    • v.72 no.3
    • /
    • pp.318-322
    • /
    • 2012
  • Sarcoidosis is an inflammatory disease involving multiple-organs with an unknown cause. The new onset of sarcoidosis associated with therapeutic agents has been observed in 3 clinical settings; tumor necrosis factor antagonists in autoimmune rheumatologic diseases, interferon alpha with or without ribavirin in patients with chronic hepatitis C or melanoma, and antineoplastic agent-associated sarcoidosis in patients with hematologic malignancies. Here, we report a female patient who developed sarcoidosis after capecitabine treatment as an adjuvant chemotherapy for sigmoid colon cancer. To our knowledge, this is the first report of a capecitabine-induced sarcoidosis.